South Carolina Center Health Equity Consortium (SC CHEC): Summer Undergraduate Research Training Program â Administrative Supplement

南卡罗来纳医科大学(MUSC)、南卡罗来纳大学(USC)和三所 历史上的黑人学院/大学-克拉夫林大学(CU)、南卡罗来纳州立大学(SCSU)和 Voorhees College(VC)-在南卡罗来纳州癌症健康公平的更大支持下联合起来 联盟(SC CHEC)为R25E NIH/NCI癌症教育资助计划开发此应用程序。 这些机构共同创建了一个创新的、跨机构的、为期14周的暑期课程。这是 结合了一个动手的实验室研究培训平台和由国家一些 领导癌症研究人员吸引和催化新一代多样化的生物医学科学家。在 这项为期五年的新计划，80名本科生大三和大四学生(指定为SC CHEC学生研究员) 来自南加州大学、加州大学、南加州大学和VC的研究人员将与南加州大学霍林斯癌症中心的研究人员接触，该中心是一家全国性的 癌症研究所(NCI)指定的癌症中心，让他们接触到生物医学研究的最新进展 跨越基础、临床和人口科学，重点关注南方癌症差异动态 卡罗莱纳(南卡罗来纳州)。这一新计划的课程和培训重点是四个最不同的 SC-乳腺癌、前列腺癌、头/颈癌和子宫颈癌的发病率、发病率和死亡率 癌症。被诊断为这四种癌症的患者的健康结果受到种族的强烈影响， 种族、城乡居住地、社会经济地位，以及潜在的生物学。此R25E计划的主要 战略将在当代背景下采用面对面的课堂和实验室教学 南加州大学癌症研究的科学方法。这些将由选定的临床和 以生物技术为重点的轮换、社区参与和研究生入学考试准备。这个 SC Check领导层坚信，促进员工的兴趣、职业发展和承诺 千禧一代(90后)对癌症的生物医学和生物行为研究是至关重要的 朝着实现健康公平和改善自然科学及其他领域的健康结果迈出一步。不幸的是，由于 新冠肺炎大流行，2020年夏天，SC CHECK计划无法提供癌症 对理工科本科生的研究培训是启动他们学术生涯的重要资源 从事研究工作。SC检查是一项影响很大计划。自2016年成立以来，61个SC Check学生研究员仍在本科学院/大学注册或已注册 研究生/专业学校。61名SC CHECH学生已作了77次科学报告和 共同撰写了4份同行评议的出版物(另有几份手稿正在进行中。资金 通过本行政补编提供的资料将使我们能够继续这项有价值和重要的工作。

The Medical University of South Carolina (MUSC), the University of South Carolina (USC), and three historically black colleges/universities – Claflin University (CU), South Carolina State University (SCSU), and Voorhees College (VC) – have joined forces under the larger aegis of the South Carolina Cancer Health Equity Consortium (SC CHEC) to develop this application for an R25E NIH/NCI Cancer Education Grants Program. Together, these institutions have created an innovative, inter-institutional, 14-week summer course. This is combined with a hands-on laboratory research training platform and career mentoring by some of the nation's leading cancer researchers to attract and catalyze a new generation of diverse biomedical scientists. Within this new five-year initiative, 80 undergraduate juniors and seniors (designated as SC CHEC Student Fellows) from USC, CU, SCSU, and VC will engage with investigators at the MUSC Hollings Cancer Center, a National Cancer Institute (NCI) designated cancer center, to expose them to the latest advances in biomedical research spanning basic, clinical, and population sciences with an emphasis on cancer disparity dynamics in South Carolina (SC). The curriculum and training of this new initiative are focused on four of the most disparate cancers in terms of incidence, morbidity, and mortality in SC – breast, prostate, head/neck, and cervical cancer. Health outcomes for patients diagnosed with these four cancers are strongly influenced by race, ethnicity, urban/rural residence, socioeconomic position, and potentially biology. This R25E program's primary strategy will employ in-person classroom and laboratory instruction within the context of contemporary scientific approaches to cancer research at MUSC. These will be complemented by selected clinical and biotechnology-focused rotations, community engagement, and Graduate Record Examination preparation. The SC CHEC leadership strongly believes that promoting interest, career development, and commitment from the Millennial Generation (those born in the 1990s) to cancer biomedical and biobehavioral research is a critical step to attaining health equity and improved health outcomes in SC and beyond. Unfortunately, due to the COVID-19 pandemic, during the summer of 2020, the SC CHEC program was unable to provide the cancer research training to undergraduate students in SC that is such a vital resource in kick-starting their academic research careers. The SC CHEC is a high-impact program. Since its inception in 2016, 100% of the 61 SC CHEC Student Fellows are either still enrolled in undergraduate college/university or are enrolled in graduate/professional school. The 61 SC CHEC Student Fellows have given 77 scientific presentations and co-authored 4 peer-reviewed publications (with several additional manuscripts in progress. The funding provided through this Administrative Supplement will allow us to continue this valuable and important work.